Biotech Specialty Pharma

Ligand Pharmaceuticals

10275 Science Center Drive
San Diego, CA 92121 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description New drugs that address critical unmet medical needs.

Management John L. Higgins, President and CEO; Martin D. Meglasson, PhD, Vice President, Discovery Research; Zofia E. Dziewanowska, MD, PhD, Vice President, Clinical Research; Syed Kazmi, PhD, MBA, Vice President, Business Development and Strategic Planning; John P. Sharp, Vice President, Finance and CFO; Charles Berkman, JD, Vice President, General Counsel and Secretary

Click here for Financial Data
Keywords: Oncology, Dermatology, Cardiology, cancer, hormone-related diseases, osteoporosis, metabolic disorders, cardiovascular, inflammatory diseases, gene transcription technology


Updated: Sept. 19, 2012


Ligand Pharmaceuticals, Inc. discovers, develops and markets small molecule drugs to address critical, unmet medical needs.......view more

Products / Services

Ligand markets four oncology and dermatology products in the United States ' ONTAK, Targretin capsules, Targretin gel and Panretin gel. Ligand's fifth and newest product, AVINZA, is a treatment for ch......view more

Technology / Differentiation

Ligand produced a diverse portfolio of technologies and assets across numerous therapeutic areas, drug targets, and industry partners. They offer investors an opportunity to spread their risk while in...view more


Ligand's network of major pharmaceutical partners is developing products for men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases...view more